Betahistine in vertebro-basilar insufficiency
The aim of the study was to observe the usefulness of Betaserc in therapy of vestibular disorders in the patients with vertebro-basilar insufficiency.
Publications tagged as
Betahistine
Investigation of betaserc in patients with auditory and vestibular disturbances
The AIM of this investigation is to evaluate the effect of Betaserc – 16 and 8 mg on the patients (workers in the system of transport), with vascular auditory and vestibular disturbances.
The effect of betahistine (betaserc) on vestibular function in vertebro-basilar insufficiency
The aim of the study was to observe the usefulness of Betaserc in therapy of vestibular disorders in the patients with vertebro-basilar insufficiency. 80 patients (43 female, 37 male) were tested on the base of videonystagmography, stabilometry and brain stem auditory evoked potentials. Betaserc was ordered in two separate doses: 3x 8mg and 3x [...]
A choice of disease for studying vestibular compensation in man : the betahistine example
The author proposes, as disease for the study of drugs activity on vestibular compensation mechanisms in man, a peripheral labyrinthine disease without spontaneous nystagmus of type II or III.
He evaluates the state of compensation by the evolution of static posturography parameters and by the score of Norre’s VHT (vestibular habituation training) during an observation period [...]
Fixed combination of cinnarizine and dimenhydrinate versus betahistine dimesylate in the treatment of ménière’s disease: a rando
In a randomized, double-blind clinical study, we evaluated the efficacy and tolerability of the fixed combination of cinnarizine, 20 mg, and dimenhydrinate, 40 mg (Arlevert [ARL]) in comparison to betahistine dimesylate (12 mg) in 82 patients suffering from Ménière’s disease for at least 3 months and showing the characteristic triad of symptoms (paroxysmal vertigo attacks, [...]
